Key Market Indicators
Sales of Hungarian Blood and Blood Forming Organs Medicine are projected to reach $210.5 million by 2026. This is an increase of 1% year-on-year since 2004. In 2021, Hungary ranked 20th in the world, behind Slovakia at $197.2 million. Germany, Italy, and South Korea respectively ranked 2nd, 3rd, and 4th. Hospital discharges due to Anemia in Hungary are expected to decrease by 0.8% CAGR from 2021 to 2026. Since 2009, demand for this medicine has dropped by 2.5% year-on-year. In 2021, Hungary ranked 10th, behind Canada at 15,530 hospital discharges. Germany, the United Kingdom, and Poland respectively ranked 2nd, 3rd, and 4th.
